The locomotor behavior of 11–12-week-old male or female Syt1 cKODA mice was recorded using an infrared actimeter (Superflex sensor version 4.6, Omnitech) using the Fusion software (v5.6 Superflex Edition, RRID:SCR_017972). A chamber partition was used to measure two mice at a time. Subjects were not given time to acclimate and spent a total of 60 min in the chamber with the following protocol: the first 20 min was used to record basal locomotion, while the following 40 min was used to record locomotion after saline or drug administration (i.p.). Drug treatments correspond to a single dose of cocaine hydrochloride at 20 mg/kg (Medisca, cat# 53-21-4, Canada) or D-amphetamine sulfate at 5 mg/kg (Tocris, 2813, UK) at doses known to increase locomotion87 (link),88 (link). SCH23390-HCl (Sigma, D-054, Canada) at 50 µg/kg, quinpirole-HCl at 0.2 mg/kg (Sigma, Q-102, Canada) and raclopride l-tartrate at 1 mg/kg (Sigma, R-121, Canada) were also used at selected high doses known to reduce locomotion in the open field89 (link)–91 (link). Each drug was diluted into 0.9% sodium chloride saline solution (Halyard, #cat 116). For each drug tested, a different cohort of mice was used. Results are presented as the mean of the traveled distance.
Free full text: Click here